Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Replenine-VF in Haemophilia B Surgery
NCT02250573Phase 3Completed
- Sponsor
- Bio Products Laboratory
- Start
- Dec 2005
- Primary completion
- Apr 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of coagulation factor IX human in hemophilia B (HB), sponsored by Bio Products Laboratory. Started Dec 2005; status: completed.
02
Drugs
coagulation factor IX human
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on NCT02250573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02250573.